Topical Ophthalmic Administration of VIAN-c4551 Antiangiogenic Peptide for Diabetic Macular Edema: Preclinical Efficacy and Ocular Pharmacokinetics
Elva Adán‐Castro, Magdalena Zamora, Daniela Granados-Carrasco…·Carmen Clapp
This study evaluates VIAN-c4551 eye drops for treating diabetic macular edema, showing they reach therapeutic concentrations in the retina and reduce vascular leakage.